Driving research of Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS),
Post Treatment Lyme Disease Syndrome (PTLDS), Fibromyalgia and Long Covid

Highlights of the January 2018 Launch Meeting for the ME / CFS Collaborative Research Center at Stanford

It’s #OMFScienceWednesday! Today we celebrate the launch of the ME/CFS Collaborative Research Center at Stanford, funded by OMF. The Stanford research team got back to work this week, and met up to plan out the projects that are now possible because of this generous funding.

Several points were discussed at the launch meeting:
1) Ron Davis welcomed everyone back, and talked about how excited he is for the team to ramp up their research, how much potential he sees in the science especially because of this additional funding, and how grateful he is to OMF for providing it;
2) Linda Tannenbaum, our CEO/President, reinforced OMF’s mission to fund research that identifies treatments and a cure, underscoring the urgency for patients;
3) A major priority is publishing the results the team has generated so far, including the potential diagnostic platform, and the big data studies in severely ill patients and families;
4) Establishing a biobank of samples where standardized analyses have been performed, that can be shared across all project teams;
5) Brainstorming on each of the individual projects (T cells and molecular immunology, extended big data study in families, diagnostic and drug screening technology)
6) Methods for data sharing and open communication with the patient community.

You’ll be hearing regular updates from these project teams in the coming months! Be sure to stay updated by liking our Facebook page if you haven’t already.
To read more about the ME/CFS Collaborative Research Center at Stanford, check out: /collaborative-research-center-stanford/

Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS) Post Treatment Lyme Disease Syndrome (PTLDS), Fibromyalgia Leading Research. Delivering Hope.Open Medicine Foundation®

What are the advantages of giving from your Donor Advised Fund (DAF)?

  • Your gifts to your donor advised fund entitle you to an immediate income tax deduction at the time of contribution.
  • You avoid capital gains tax on appreciated assets you place in your donor advised fund.
  • Your fund’s investment gains accumulate tax free.
  • Funds are distributed to Open Medicine Foundation in your name and immediately put to use to support our worldwide research efforts.

How do I make a donation through my DAF?

Just click on the DAF widget below. It is simple and convenient to find your fund among the over 900 funds in our system.

Still can’t find your fund? 

  • Request a grant distribution through your Donor Advised Fund sponsor
  • Be sure to use OMF’s EIN #26-4712664
  • You can also designate OMF as a beneficiary for your Donor Advised Fund
  • Questions? Give us a call at 650-242-8669